148 related articles for article (PubMed ID: 193018)
1. Mechanisms of escape from immune surveillance.
Klein G
Natl Cancer Inst Monogr; 1976 Nov; 44():135-6. PubMed ID: 193018
[TBL] [Abstract][Full Text] [Related]
2. Immune surveillance--a powerful mechanism with a limited range.
Klein G
Natl Cancer Inst Monogr; 1976 Nov; 44():109-13. PubMed ID: 193016
[TBL] [Abstract][Full Text] [Related]
3. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
Levy JP; Leclerc JC
Adv Cancer Res; 1977; 24():1-66. PubMed ID: 66859
[No Abstract] [Full Text] [Related]
4. Immunology and malignant disease.
Klein E; Cochran AJ
Haematologia (Budap); 1971; 5(3):179-203. PubMed ID: 4108507
[No Abstract] [Full Text] [Related]
5. [Rejection of non viral tumors caused by infection with murine sarcoma virus].
Basombrio MA
Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370
[No Abstract] [Full Text] [Related]
6. Viral aetiopathogenesis of tumors.
Klein E
Boll Ist Sieroter Milan; 1971; 50(3):140-51. PubMed ID: 4111986
[No Abstract] [Full Text] [Related]
7. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
Harada M; Pearson G; Redmon L; Winters E; Kasuga S
J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
[TBL] [Abstract][Full Text] [Related]
8. Tumor associated immune reactions in cancer patients.
Klein G
Schweiz Med Wochenschr; 1972 Aug; 102(33):1163-5. PubMed ID: 4341124
[No Abstract] [Full Text] [Related]
9. Tumor-associated membrane antigens and the antitumor immune reactions.
Levy JP; Kourilsky FM
Transplant Proc; 1973 Dec; 5(4):1435-40. PubMed ID: 4130056
[No Abstract] [Full Text] [Related]
10. The immunology of tumors.
Burk MW; Mckhann CF
Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
[No Abstract] [Full Text] [Related]
11. Proceedings: Proposed mechanisms by which autochthonous neoplasms escape immune rejection.
Coggin JH; Ambrose KR; Dierlam PJ; Anderson NG
Cancer Res; 1974 Aug; 34(8):2092-101. PubMed ID: 4366506
[No Abstract] [Full Text] [Related]
12. Spontaneous tumor regression: possible relationship to in vitro parameters of tumor immunity.
Hellström KE; Hellström I
Natl Cancer Inst Monogr; 1976 Nov; 44():131-4. PubMed ID: 193017
[TBL] [Abstract][Full Text] [Related]
13. Metastatic spread and "escape" from the immune defenses of the host.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():125-9. PubMed ID: 1025472
[TBL] [Abstract][Full Text] [Related]
14. [Tumour antigens inducing immune reactions].
Burtin P
Ann Immunol (Paris); 1977; 128(1-2):507-16. PubMed ID: 192132
[TBL] [Abstract][Full Text] [Related]
15. [Tumour immunology (author's transl)].
Sellin D
Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():341-9. PubMed ID: 88727
[TBL] [Abstract][Full Text] [Related]
16. Workshop in human tumor immunology.
Oettgen HF; Bean MA; Klein G
Cancer Res; 1972 Dec; 32(12):2845-53. PubMed ID: 4345410
[No Abstract] [Full Text] [Related]
17. Squamous-cell carcinoma, Kaposi's sarcoma and Burkitt's lymphoma are consequences of impaired immune surveillance of ubiquitous viruses in acquired immune deficiency syndrome, allograft recipients and tropical African patients.
Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H
IARC Sci Publ; 1984; (63):749-70. PubMed ID: 6100288
[TBL] [Abstract][Full Text] [Related]
18. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
Powell TJ; Spann R; Nguyenduc M; Lamon EW
J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772
[TBL] [Abstract][Full Text] [Related]
19. [Tumor immunology].
Cerni CM
Subsid Med; 1974; 2():21-5. PubMed ID: 4606048
[No Abstract] [Full Text] [Related]
20. Cellular and humoral immune interactions during neoplastic development.
Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA
Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716
[No Abstract] [Full Text] [Related]
[Next] [New Search]
